Lichen International (LICN) Liabilities and Shareholders Equity (2021 - 2025)

Lichen International (LICN) has reported Liabilities and Shareholders Equity for 5 consecutive years, with $75.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 5.34% year-over-year to $75.6 million; the TTM figure through Dec 2025 stood at $295.2 million (up 7.68% YoY), while the FY2025 annual figure was $75.6 million, down 5.34% from the prior year.
• Liabilities and Shareholders Equity rose to $75.6 million in Q4 2025 per LICN's latest filing, from $67.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $79.8 million in Q4 2024 and bottomed at $42.9 million in Q4 2021.
• Historically, Liabilities and Shareholders Equity has averaged $63.3 million across 5 years, with a median of $66.4 million in 2023.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity soared 40.88% — and 2025, when it decreased 7.42%.
• Lichen International's Liabilities and Shareholders Equity stood at $42.9 million in 2021, then rose by 8.34% to $46.5 million in 2022, then jumped by 40.88% to $65.5 million in 2023, then rose by 21.81% to $79.8 million in 2024, then fell by 5.34% to $75.6 million in 2025.
• Business Quant data shows LICN's Liabilities and Shareholders Equity at $75.6 million in Q4 2025, $67.2 million in Q2 2025, and $79.8 million in Q4 2024.